Skip to content

KLRS KLRS Common Stock

Common Stock at other companies

Eli Lilly logo
Eli LillyLLY
$590M-0.4%
Amgen logo
AmgenAMGN
2.8B0.0%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$83K+20.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$22K+37.5%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$6K+20.0%
AbbVie logo
AbbVieABBV
$18M0.0%

Other financials

Income statement

See full
Operating income-$11.8M-14.3%
Net income-$10.9M-6.5%
EPS (diluted)-$0.46+81.7%

Balance sheet

See full
Cash & equivalents$34.4M-65.9%
Total debt$1.4M
Total equity$68.6M+7.3%
Total assets$109.8M+6.5%

Cash flow

See full
Operating cash flow-$11.6M-55.6%
CapEx$17.0K
Free cash flow-$7.1M

Valuation

See full
Market cap$96.83M+136%
Enterprise value$63.82M

Returns & leverage

See full
Return on equity-66.6%
Debt / equity
Current ratio12.2×-2.1×

Where this comes from

Reported directly by KLRS in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: KLRS’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KLRS's common stock?
KLRS (KLRS) reported common stock of $2K in Q1 2026.
How has KLRS's common stock changed year-over-year?
KLRS's common stock decreased by 0.0% year-over-year, from $2K to $2K.
What is the long-term trend for KLRS's common stock?
Over 4 years (2021 to 2025), KLRS's common stock has grown at a -26.9% compound annual growth rate (CAGR), from $7K to $2K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).